Delivery Order SPE2DB20D1004-SPE2DB25FNEPQ

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,182.80, is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of January 10, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $2,668.80 and covers the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4565314964 MULTAQ 400 MG TABLET 60S. The contract has a firm fixed price, ceiling value of $2,220.92, and a period of performance through August 2, 2024. This contract was not set aside for any specific business type. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $1,451.96, is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 15, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,504,610 MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of August 20, 2024 and a ceiling value of $8,771.60. It is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,034.70 firm fixed price contract is for the delivery of MULTAQ 400 MG TABLET 60S, a cardiovascular medication. The ultimate completion date is November 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $7,502.94, is for the delivery of 4562093611 MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of September 8, 2023 and is a firm fixed-price delivery order. The contract was not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp, a major...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,097.32, is for the provision of MULTAQ 400 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of January 13, 2025 and is a Firm Fixed Price, Delivery Order type contract. The contract was not set-aside for any specific business category....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,042.08, is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,467.70, is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through January 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNEPQ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,811.56, is for the delivery of 4567088222 MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of January 30, 2025, and is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/30/25, 9:58 AM